conventional DST for RIF resistance was 100%. For the initial assay development, we tested the assay for mutations within the tuberculosis isolates were detected by our HRM assay. We also analyzed 10 drug- isolates with different mutations are shown in Figure 1 . Visually, samples with isolates had mutations outside the rpoB core. Our results also indicated that the specificity of the HRM was slightly lower than 1 7 8 those found in previous studies [23, 24, 29, 30] . The possible reasons for false-1 7 9 positive results might be as follows: it is possible that these mutations are silent or In recent years, several rapid molecular assays including commercial kits and 1 8 2
Xpert MTB/RIF have been used for the diagnosis of drug resistance in M. and instruments are also very important in the accuracy of HRM. All of these 2 0 7
parameters may limit the extensive application of HRM to some degree. Furthermore, standard optimization procedures must be established before HRM is HRM also can increase the risk of contamination. there would be an increased chance of finding non-rpoB mutated resistant strains. In conclusion, the analysis has demonstrated that the diagnostic accuracy of HRM H  i  g  h  r  e  s  o  l  u  t  i  o  n  m  e  l  t  i  n  g  a  n  a  l  y  s  i  s  f  o  r  t  h  e  r  a  p  i  d  a  n  d  s  e  n  s  i  t  i  v  e  d  e  t  e  c  t  i  o  n  o  f   3  3  0   m  u  t  a  t  i  o  n  s  i  n  c  l  i  n  i  c  a  l  s  a  m  p  l  e  s  :  K  R  A  S  c  o  d  o  n  1  2  a  n  d  1  3  m  u  t  a  t  i  o  n  s  i  n  n  o  n  -s  m  a  l  l  c  e  l  l  l  u  n  g  c  a  n  c  e  r  .   3  3  1  B  M  C  c  a  n  c  e  r  ,  2  0  0  6  .  6  (  1  )  :  p  .  2  9  5  .  3  3  2  3  7  .  W  i  t  t  w  e  r  ,  C  .  T  .  ,   H  i  g  h  -r  e  s  o  l  u  t  i  o  n  D  N  A  m  e  l  t  i  n  g  a  n  a  l  y  s  i  s  :  a  d  v  a  n  c  e  m  e  n  t  s  a  n  d  l  i  m  i  t  a  t  i  o  n  s  .   H  u  m  a  n  3  3  3  m  u  t  a  t  i 
